Canagliflozin
21YXYJ0111
Unknown small_molecule active
Quick answer
Canagliflozin for Type 2 Diabetes Mellitus With Complication is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Type 2 Diabetes Mellitus With Complication
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active